ID
Bron
Verkorte titel
Aandoening
S. aureus, staphylococcus aureus
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Microbiome composition of the nose
Achtergrond van het onderzoek
Rationale: This study will investigate the interaction between host nasal microbiome and Staphylococcus aureus to elicit the influence of host factors on success of dominant MRSA clones.
Objective: To identify nasal microbial communities associated with Staphylococcus aureus carriage and study the influence over time of S. aureus-targeted decolonization treatment on these microbial communities.
Study design: Prospective interventional cohort study with 2 groups.
Study population: A total of 70 healthy Dutch volunteers will be recruited to participate in the study. These volunteers will be grouped based on their S. aureus carrier status, either as carriers or noncarriers.
Intervention: After inclusion and determination of carrier status, all volunteers will be treated with Mupirocin (Bactroban) 2% nasal ointment and Chlorhexidine gluconate (Hibiscrub®) 4% cutaneous body wash solution within the product indication and in accordance with local clinical practice.
Main study parameters/endpoints: Microbiome composition of the nose, to be analysed in relation to S. aureus carrier status and decolonization.
Onderzoeksopzet
After a two-week screening period for S. aureus nasal carriage, eligible volunteers are included and followed for 6 months.
Onderzoeksproduct en/of interventie
5 day treatment with Bactroban 2% nasal ointment (mupirocin) and Hibiscrub 4% cutaneous solution (chlorhexidine gluconate) at the start of the study
Publiek
Margreet C. Vos
Wytemaweg 80, Room Na-901k
Rotterdam 3015 CN
The Netherlands
0107033510
m.vos@erasmusmc.nl
Wetenschappelijk
Margreet C. Vos
Wytemaweg 80, Room Na-901k
Rotterdam 3015 CN
The Netherlands
0107033510
m.vos@erasmusmc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Volunteers must be over 18 years old
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Employee of the Erasmus MC
- Intermittent carrier of Staphylococcus aureus
- Use of drugs influencing microbiome in 3 months prior to the study period i.e. antibiotics, antiparasitics or
antifungals
- Regular use of commercial probiotics in 3 months prior to the study period
- Known allergy to components of the intervention treatment, consisting of mupirocin nasal ointment and chlorhexidine wash
- Pregnant and breastfeeding women, due to limited scientific evidence on adverse effects of mupirocin treatment during pregnancy and breastfeeding.
- Known chronic diseases affecting the immune system (such as diabetes mellitus, renal insufficiency, COPD,
heart diseases, immunocompromised status (HIV, AIDS), skin diseases such as severe eczema or use of
immunosuppressant drugs
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL7254 |
NTR-old | NTR7461 |
CCMO | NL65791.078.18 |
OMON | NL-OMON48845 |